Valuation: Proteome Sciences plc

Market Cap 5.1M 6.74M 5.95M 5.63M 9.57M 647M 9.66M 67.5M 26.02M 330M 25.3M 24.75M 1.06B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 20.09M 26.53M 23.42M 22.15M 37.67M 2.55B 38.04M 266M 102M 1.3B 99.63M 97.46M 4.18B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day+3.93%
1 week-1.69%
Current month-6.13%
1 month-6.13%
3 months-15.16%
6 months-9.35%
Current year-41.80%
1 week 1.2
Extreme 1.2
1.69
1 month 1.11
Extreme 1.11
1.79
Current year 1.11
Extreme 1.11
4.4
1 year 1.11
Extreme 1.11
4.4
3 years 1.11
Extreme 1.11
7.5
5 years 1.11
Extreme 1.11
8.79
10 years 1.11
Extreme 1.11
11.75
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap. Importance
4/14/23 A
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/14/23 A
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
4/6/23 A
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
+3.93%-1.69%-17.09%-76.63% 6.51M
-0.03%-1.97%-24.41%+2.88% 175B
-2.69%-5.08%-7.57%+10.67% 114B
+1.25%-2.81%+0.20%+68.22% 57.98B
-1.01%+0.70%-1.42%-30.74% 50.07B
-1.00%+2.74%+13.85%+53.00% 50.13B
-0.05%-2.84%+29.12%-9.24% 32.71B
-0.26%+9.45% - - 30.77B
+0.26%+4.10%+44.02%-0.65% 26.44B
+0.28%+7.74%+26.61%-1.63% 23.96B
Average +0.30%-0.12%+7.03%+1.77% 56.13B
Weighted average by Cap. -0.47%-0.77%-3.29%+12.14%

Financials

2024 2025
Net sales 4.89M 6.45M 5.7M 5.39M 9.16M 619M 9.25M 64.64M 24.91M 316M 24.23M 23.71M 1.02B 3.76M 4.96M 4.38M 4.14M 7.04M 476M 7.11M 49.68M 19.15M 243M 18.63M 18.22M 782M
Net income -3.41M -4.5M -3.97M -3.76M -6.39M -432M -6.45M -45.05M -17.36M -220M -16.89M -16.52M -709M -3.06M -4.04M -3.57M -3.38M -5.74M -388M -5.8M -40.49M -15.61M -198M -15.18M -14.85M -637M
Net Debt 13.39M 17.69M 15.61M 14.77M 25.11M 1.7B 25.36M 177M 68.28M 867M 66.42M 64.97M 2.79B 14.99M 19.79M 17.47M 16.53M 28.1M 1.9B 28.38M 198M 76.42M 970M 74.33M 72.71M 3.12B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
29/09/26 GBX 1.455 +3.93% 0
28/09/26 GBX 1.400 +5.66% 107,499
25/09/26 GBX 1.325 -8.62% 115,426
24/09/26 GBX 1.450 -3.01% 59
23/09/26 GBX 1.495 +1.01% 63,616